Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

American Medical Electronics

This article was originally published in The Gray Sheet

Executive Summary

Removes Joseph Mooibroek as president and CEO but does not ask him to resign as a director of AME. The company says the move, which comes one week after AME's four outside directors asked Mooibroek to resign ("The Gray Sheet" April 4, In Brief), is in line with its plans to grow more aggressively by expanding into international markets and diversifying its product line. "The CEO search will focus on candidates with demonstrated ability to grow and diversify the company to the $100 million sales level and beyond," AME Chairman Arthur Schwalm says. Schwalm will serve as interim CEO until Mooibroek's replacement is named

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel